NCT00466219View on ClinicalTrials.gov

Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver Transplant

PHASE3CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 31, 2002

Study Completion Date

December 31, 2006

Conditions
Hepatitis C
Interventions
DRUG

Ribavirin

DRUG

Pegylated interferon alpha2a

All Listed Sponsors
lead

University Hospital, Geneva

OTHER

NCT00466219 - Ribavirin/Pegasys Treatment of Recurrent Hepatitis C After Liver Transplant | Biotech Hunter | Biotech Hunter